Categories: Wire Stories

Global Hyaluronic Acid-based Dermal Fillers Market Report 2021: Market to Reach $5.8 Billion by 2027 – Single Phase Segment to Account for $3.3 Billion – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Hyaluronic Acid-based Dermal Fillers – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.

Global Hyaluronic Acid-based Dermal Fillers Market to Reach $5.8 Billion by 2027

Amid the COVID-19 crisis, the global market for Hyaluronic Acid-based Dermal Fillers estimated at US$3.8 Billion in the year 2020, is projected to reach a revised size of US$5.8 Billion by 2027, growing at a CAGR of 6.2% over the period 2020-2027.

Single Phase, one of the segments analyzed in the report, is projected to record 6.5% CAGR and reach US$3.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Duplex segment is readjusted to a revised 5.9% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1 Billion, While China is Forecast to Grow at 9.6% CAGR

The Hyaluronic Acid-based Dermal Fillers market in the U.S. is estimated at US$1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2027 trailing a CAGR of 9.5% over the analysis period 2020 to 2027.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.4% and 5.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4% CAGR.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS (Total 43 Featured):

  • Allergan
  • Anika Therapeutics, Inc.
  • Bio Plus Co., Ltd.
  • Bioxis Pharmaceuticals
  • Bohus Biotech AB
  • Candela Corporation
  • Galderma Laboratories L.P.
  • Genzyme Corp.
  • Inamed Corp.
  • Laboratoires Vivacy
  • LG Life Sciences, Ltd.
  • Medicis Aesthetics Holdings, Inc.
  • Merz Pharmaceuticals
  • Sculpt Luxury Dermal Fillers Ltd.
  • Sinclair Pharma

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

  • UNITED STATES
  • CANADA
  • JAPAN
  • CHINA
  • EUROPE
  • FRANCE
  • GERMANY
  • ITALY
  • UNITED KINGDOM
  • SPAIN
  • RUSSIA
  • REST OF EUROPE
  • ASIA-PACIFIC
  • AUSTRALIA
  • INDIA
  • SOUTH KOREA
  • REST OF ASIA-PACIFIC
  • LATIN AMERICA
  • ARGENTINA
  • BRAZIL
  • MEXICO
  • REST OF LATIN AMERICA
  • MIDDLE EAST
  • IRAN
  • ISRAEL
  • SAUDI ARABIA
  • UNITED ARAB EMIRATES
  • REST OF MIDDLE EAST
  • AFRICA

IV. COMPETITION

  • Total Companies Profiled: 43

For more information about this report visit https://www.researchandmarkets.com/r/qdyvcv

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Alex

Recent Posts

Hong Kong Design Centre Welcomes ‘Blueprint for Arts and Culture and Creative Industries Development’

HONG KONG SAR - Media OutReach Newswire - 27 November 2024 - Hong Kong Design…

1 hour ago

Preserving the beauty of nature – a bond that links Lancang-Mekong countries

CHENGDU CITY, CHINA - Media OutReach Newswire - 27 November 2024 - Taking its source…

1 hour ago

Arirang TV presents Korea’s one-day trip entertainment show “¡Hola, Corea!” for South American viewers

- Arirang TV's one-day trip entertainment “¡Hola, Corea!”, specially produced for South American viewers, will…

3 hours ago

Gartner Announces the Gartner CFO & Finance Executive Conference 2025 in Sydney

--(BUSINESS WIRE)--Gartner, Inc. (NYSE: IT): What:   Gartner CFO and Finance Executive Conference 2025  …

3 hours ago

Northern Trust Asset Management 2025 Global Investment Outlook: Expect U.S. Stocks to Outperform; High Yield Bond Market Is Attractive

Earnings Growth Backs U.S. Equities; Strong Credit Quality Supports High Yield Market; U.S. Money Market…

3 hours ago

S.BIOMEDICS Investigational Cell Therapy for Parkinson’s Disease With TED-A9 Shows Positive Data at 12-months in Phase 1/2a Clinical Trial

TED-A9 is high-purity ventral midbrain dopaminergic progenitor cells derived from human embryonic stem cells (hESCs)…

3 hours ago